Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Jan 27, 2023; 15(1): 105-113
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.105
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.105
Figure 1 Study group compared to the control group.
A: Tumor lengths decreased in the study group compared to the control group; B: Serum alpha-fetoprotein levels decreased in the study group compared to the control group. Control group: Treated with transarterial chemoembolization (TACE); Study group: Treated with TACE and radioactive iodine implantation. AFP: Alpha-fetoprotein.
Figure 2 Kaplan-Meier survival curvefor the two groups of patients.
Control group: Treated with transarterial chemoembolization (TACE); Study group: Treated with TACE and radioactive iodine implantation.
- Citation: Wang L, Huang K, Zhang Y, Wu YF, Yue ZD, Fan ZH, Liu FQ, Li YW, Dong J. Short-term efficacy assessment of transarterial chemoembolization combined with radioactive iodine therapy in primary hepatocellular carcinoma. World J Gastrointest Surg 2023; 15(1): 105-113
- URL: https://www.wjgnet.com/1948-9366/full/v15/i1/105.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i1.105